BioInvent International AB (BINV) — Financial Flexibility Index
BioInvent International AB (BINV) has a Financial Flexibility Index of 0.64x as of June 2025. Free cash flow of Skr68.16 Million (operating CF Skr66.78 Million minus capex Skr1.38 Million) represents 1% of total liabilities (Skr105.93 Million). Also explore BioInvent International AB equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioInvent International AB Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for BioInvent International AB across 23 annual periods. Check BINV capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BioInvent International AB (2002–2024)
Year-by-year free cash flow to debt coverage for BioInvent International AB. For the full company profile including market capitalisation, see BINV market cap.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.58x | Skr-370.44 Million | Skr-380.47 Million | Skr103.42 Million | ▲ +1.3% |
| 2023 | -3.63x | Skr-328.39 Million | Skr-341.69 Million | Skr90.45 Million | ▼ -1235.1% |
| 2022 | -0.27x | Skr-28.85 Million | Skr-41.23 Million | Skr106.09 Million | ▲ +90.6% |
| 2021 | -2.90x | Skr-232.58 Million | Skr-245.84 Million | Skr80.32 Million | ▼ -206.2% |
| 2020 | -0.95x | Skr-55.92 Million | Skr-62.62 Million | Skr59.14 Million | ▲ +55.9% |
| 2019 | -2.15x | Skr-121.59 Million | Skr-125.43 Million | Skr56.67 Million | ▲ +48.9% |
| 2018 | -4.20x | Skr-137.55 Million | Skr-141.39 Million | Skr32.78 Million | ▼ -181.3% |
| 2017 | -1.49x | Skr-59.40 Million | Skr-75.88 Million | Skr39.82 Million | ▼ -2.5% |
| 2016 | -1.45x | Skr-66.73 Million | Skr-72.05 Million | Skr45.86 Million | ▲ +49.4% |
| 2015 | -2.88x | Skr-71.90 Million | Skr-72.57 Million | Skr24.99 Million | ▲ +17.5% |
| 2014 | -3.49x | Skr-75.61 Million | Skr-76.03 Million | Skr21.68 Million | ▼ -107.1% |
| 2013 | -1.68x | Skr-54.60 Million | Skr-54.65 Million | Skr32.43 Million | ▲ +31.9% |
| 2012 | -2.47x | Skr-170.32 Million | Skr-170.38 Million | Skr68.92 Million | ▼ -231.6% |
| 2011 | -0.75x | Skr-50.54 Million | Skr-55.45 Million | Skr67.81 Million | ▲ +57.9% |
| 2010 | -1.77x | Skr-113.07 Million | Skr-117.70 Million | Skr63.84 Million | ▲ +0.6% |
| 2009 | -1.78x | Skr-125.85 Million | Skr-127.14 Million | Skr70.61 Million | ▼ -299.2% |
| 2008 | 0.89x | Skr57.37 Million | Skr43.73 Million | Skr64.13 Million | ▲ +207.7% |
| 2007 | 0.29x | Skr16.54 Million | Skr12.63 Million | Skr56.88 Million | ▲ +112.0% |
| 2006 | -2.42x | Skr-92.27 Million | Skr-101.23 Million | Skr38.18 Million | ▼ -39.3% |
| 2005 | -1.73x | Skr-82.11 Million | Skr-105.48 Million | Skr47.34 Million | ▲ +46.4% |
| 2004 | -3.23x | Skr-83.18 Million | Skr-88.74 Million | Skr25.73 Million | ▼ -116.8% |
| 2003 | -1.49x | Skr-57.02 Million | Skr-66.25 Million | Skr38.23 Million | ▼ -399.9% |
| 2002 | 0.50x | Skr25.94 Million | Skr-10.57 Million | Skr52.16 Million | — |